Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 62 PE Ratio without NRI is 10.27 as of Sep. 19, 2026, which is 12% above its 10-year median of 9.14. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.52 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 89 Medical Distribution companies, Olba DVx Healthcare ranks better than 73.03% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-09-19), Olba DVx Healthcare's share price is 円1925.00.
Olba DVx Healthcare's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円187.51. Therefore, Olba DVx Healthcare's PE Ratio without NRI for today is 10.27.
During the past 13 years, Olba DVx Healthcare's highest PE Ratio without NRI was 33.18. The lowest was 2.21. And the median was 9.14.
Olba DVx Healthcare's EPS (Basic) for the
three
months ended in Mar. 2026 was 円71.10.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円187.66.
Olba DVx Healthcare (TSE:2689) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Olba DVx Healthcare PE Ratio without NRI Related Terms
Olba DVx Healthcare PE Ratio without NRI Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's PE Ratio without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2689 vs MCK, COR, CAH: PE Ratio without NRI Comparison
For the Medical Distribution subindustry, Olba DVx Healthcare's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare PE Ratio without NRI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's PE Ratio without NRI falls into.
Olba DVx Healthcare PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Olba DVx Healthcare's Share Price of today is 円1925.00.
Olba DVx Healthcare's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円187.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Olba DVx Healthcare (TSE:2689) has a PE Ratio without NRI of 10.27 as of Sep. 19, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Olba DVx Healthcare and its competitors. This is 12% above median its historical median of 9.14. Over the past decade, Olba DVx Healthcare's PE Ratio without NRI has ranged from 2.21 to 33.18. According to the industry distribution chart, Olba DVx Healthcare ranks #24 out of 89 companies in the Medical Distribution industry, placing it in the top 27%.
Is Olba DVx Healthcare's PE Ratio without NRI too high?
Olba DVx Healthcare's current PE Ratio without NRI of 10.27 is 12% above median its 10-year median of 9.14. Over the past 10 years, this metric has ranged from a low of 2.21 to a high of 33.18. The Medical Distribution industry median PE Ratio without NRI is 15.74. Olba DVx Healthcare's value of 10.27 is 34.8% below this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #24 out of 89 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's PE Ratio without NRI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #24 out of 89 companies for PE Ratio without NRI. This puts Olba DVx Healthcare in the upper half of its industry. The industry median PE Ratio without NRI is 15.74. Olba DVx Healthcare's value of 10.27 is 34.8% below this benchmark. Historically, Olba DVx Healthcare's own PE Ratio without NRI has ranged from 2.21 to 33.18 over the past decade. While the company's 10-year median is 9.14 vs. the industry median of 15.74, Olba DVx Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Distribution company?
The median PE Ratio without NRI among Medical Distribution companies is 15.74, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current PE Ratio without NRI of 10.27 is 34.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median PE Ratio without NRI is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current PE Ratio without NRI is 10.27, which is 12% above median its own 10-year median of 9.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.52, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current PE Ratio without NRI is 10.27, which is 12% above median its 10-year median of 9.14 and 34.8% below the Medical Distribution industry median of 15.74. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current PE Ratio without NRI is 10.27 as of Sep. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.52.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
PE Ratio without NRI: 10.27 (12% above median its 10-year median of 9.14)
GF Value™: 円2,164.52 vs. price of 円1,925.00 (11.1% below fair value)
Industry Position: 34.8% below the Medical Distribution median (#24 of 89)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
